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Abstract 
The influenza A virus subtypes H1N1, H1N2 and H3N2 are prevalent in pig 
populations worldwide. All scientific data point towards swine as the key host species 
for new human influenza pandemics, which have been suggested to evolve in pigs from 
viral genes of avian, human and porcine origin. Therefore, it is of major importance to 
record the evolution of swine influenza viruses in pigs, and in particular monitor 
hallmarks of adaptation to humans. The scope of this thesis was to increase the 
understanding of the genetics of swine influenza virus (SIV), and to investigate the 
importance of different viral gene markers in association with differences in 
pathogenicity of two viruses of H1N2 subtype in pigs. The results from this study 
demonstrate, for the first time, natural reassortment in H1N2 viruses in the pig 
populations of Sweden. These H1N2 viruses have an avian-like SIV H1N1 
haemagglutinin (HA) and a European H3N2 SIV-like neuraminidase (NA). Nucleotide 
sequence comparison revealed significant differences between the two consecutive 
H1N2 isolates. To be able to understand the genotypic differences observed in the 
genomes of these H1N2s, and to identify the genetic markers responsible for the 
differences, a reverse genetic system was developed. Four recombinant SIV H1N2 
viruses were constructed that displayed differences in virulence in mice, r1021 (more 
virulent) and r9706 (less virulent), as well as the same viruses with swapped PB1 
segments. Interestingly, the current findings showed that the replacement of the PB1 
segment of r9706 by that of r1021 increases the virulence of the virus that replicate 
with higher titer in mice lungs, while the opposite is true when PB1 r9706 is introduced 
into r1021. This study demonstrates that differences in virulence of swine influenza 
virus subtype H1N2 are attributed at least in part to the PB1 segment. The findings 
presented in this thesis support the observations concerning the continuous 
reassortment processes of SIVs in pigs, resulting in repeated and independent 
emergence of certain HA/NA combinations. This may lead to emergence of new viral 
variants of severe pathogenicity of pigs. Continuous and efficient surveillance and 
further detailed genetic and phenotypic analysis can help to identify such novel viral 
variants, having more potential to cross species barriers and to pose health risks even to 
humans and to other host species. 
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1 Introduction   
 
1.1  History and epidemiological evolution of European swine 
influenza viruses 
Influenza is a highly contagious acute respiratory viral infection that appears to 
have caused serious disease in humans since ancient times. It is a viral disease 
of global importance, caused by various different influenza viruses. Influenza 
viruses were probably responsible for the disease described by Hippocrates in 
412 BC (Hoehling, 1961), and are still causing significant mortality and 
morbidity throughout the world. Influenza viruses can infect many animal 
species and some of these infectious agents may give rise to pandemic strains 
in humans. One recent example is the case of the 2009 H1N1 pandemic 
(H1N1pdm). Most threatening is the possibility of another pandemic 
appearing, similar to the Spanish influenza of 1918, which killed more than 40 
million people (Palese, 2004; Johnson & Mueller, 2002; Hoehling, 1961).   
Influenza viruses have been isolated from various avian species and 
mammals, including humans and pigs. Swine influenza viruses (SIV) cause 
respiratory disease in pigs and can have a significant economic impact in an 
affected herd. Swine influenza (SI) was first clinically recognized at the time of 
the Spanish influenza pandemic of 1918 but the virus was not isolated and 
identified by Shope until 1930. It was shown to be influenza A virus of the 
H1N1 antigenic subtype called classical H1N1 (Shope, 1931). It was probably 
exactly the same virus affecting both humans and pigs. Nowadays three main 
subtypes of SIV are prevalent in the pig populations worldwide, H1N1, H3N2 
and H1N2 (Karasin et al., 2002; Gourreau et al., 1994), responsible for a 
highly contagious respiratory disease in pigs (Brown, 2000). The origin and 
nature of SIVs differ on different continents (Olsen et al., 2005). These   12 
differences have implication for the diagnosis and control of SIV, e.g. the 
strains used as antigens in vaccines and diagnostic test are different in Europe 
and in the United States. Also, the influenza virus can be one of many 
components in association with the porcine respiratory disease complex, of 
multifactorial aetiology (Hansen et al., 2010). In the epidemic form of the 
disease SIV moves swiftly in all parts of the swine unit as it is readily 
transmitted by contact with respiratory secretions as well as by aerosol. 
Infection causes coughing, sneezing, nasal discharge, fever, lethargy, breathing 
difficulty and depressed appetite, and can lead to morbidity rates of up to 100% 
(Olsen et al., 2006). Mortality, on the other hand, is low and recovery is 
unusually rapid, occurring within 7–10 days. 
1.1.1 Classical  H1N1 
In Europe, SIVs were first isolated in Great Britain between 1938 and 1940 
(Blakemore & Gledhill, 1941; Lamont, 1938). Nucleotide sequence analysis 
has shown that all eight genome segments of these strains were more closely 
related to the early human H1N1 strains A/Wisconsin/33 and A/Puerto 
Rico/8/34 than to the classical swine H1N1 virus (A/Sw/Iowa/1930), which 
was isolated in pigs in the US by Shope (Neumeier et al., 1994). In 1950, the 
classical swine H1N1 virus was isolated in Czechoslovakia but after that no 
SIV detection was reported in Europe for more than two decades (Dunham et 
al., 2009; Kuntz-Simon & Madec, 2009). Classical swine H1N1 viruses 
circulated in North America but were absent in Europe until 1976, when they 
were isolated from pigs imported into Italy from the United States (Nardelli et 
al., 1978). After that, H1N1 spread and became established in other European 
countries, e.g. in the Netherlands (Masurel et al., 1983), Denmark (Sorensen et 
al., 1981), and southern Sweden in 1983 (Abusugra et al., 1987; Martinsson et 
al., 1983), and in the United Kingdom (Roberts et al., 1987). In North America 
and Asia the classical swine H1N1 is still the most common isolate, but in 
Europe the H1N1 in pigs is now predominantly of avian origin (Guan et al., 
1996; Hinshaw et al., 1978). 
1.1.2 “Avian-like”  H1N1’ 
The predominant H1N1 SIVs in Europe are of wholly avian genome origin, 
and were introduced to the pig population from wild ducks in 1979 (Campitelli 
et al., 1997; Pensaert, 1981). They are called “avian-like” swine H1N1 viruses 
and are antigenically distinguishable from classical swine H1N1 influenza 
viruses. These “avian-like” viruses have a selective advantage over classical 
swine H1N1 viruses, as in Europe they have replaced the classical SI virus 
(Brown, 2000; Campitelli et al., 1997).    13
1.1.3 Human-like  H3N2 
In the early 1970s, H3N2 viruses resembling the H3N2 strain, which was 
responsible for the human 1968 Hong Kong influenza pandemic, were 
introduced into European pigs (Harkness et al., 1972).  In 1984 a reassortment 
event occurred, resulting in a new strain containing human-like H3N2 “Hong 
Kong influenza virus” surface genes (HA, NA) and the internal genes of 
“avian-like” H1N1 (Campitelli et al., 1997); and this replaced the original 
human-like swine H3N2 “Hong Kong influenza 1968” strain in circulation 
among pig populations in European countries in the 1990s (Kuntz-Simon & 
Madec, 2009). The occurrence and prevalence of SIVs vary among the 
different regions in Europe, but the avian origin H1N1 appears to be the most 
predominant subtype, followed by reassortant H3N2 and to a lower extent the 
H1N2 subtypes, which comprise viruses of diverse genetic constellations. 
1.1.4 H1N2 
As a result of further reassortment events, the first European SI H1N2 subtype 
was reported in France in 1987 (Gourreau et al., 1994). This virus was a 
reassortant between the avian-like swine H1N1 virus and the European 
reassortant human-like swine H3N2. This virus has the haemagglutinin (HA) 
gene of avian and the neuraminidase (NA) gene of human origin. The first 
European SI H1N2 subtype did not become widespread in the European pig 
populations. However, another distinct lineage of H1N2 virus did become 
widespread in European pig populations, as a reassortant variant of “human-
like” H1N2 virus identified in the UK in 1994. This virus spread to Belgium 
and other European countries during the next few years and became endemic 
(Marozin et al., 2002; Van Reeth et al., 2000; Brown et al., 1995). This 
reassortant was the result of a reassortment between a human H1N1 virus from 
the 1980s (HA protein), the “human-like” swine H3N2 virus (NA protein) and 
the “avian-like swine” H1N1 SIV, from which it “inherited” the internal 
protein genes (Brown et al., 1998). These viruses are genetically and 
antigenically different from viruses of the same subtype that had been present 
in pigs in France in 1987. Since 1998 reassortant H1N2 SIVs have been 
isolated in Italy and France (Kuntz-Simon & Madec, 2009; Marozin et al., 
2002). They are similar to the prototype H1N2 strains; the difference is that 
instead of a human HA, they have the “avian-like” HA from H1N1 SIVs. In 
Denmark an H1N2 influenza subtype was discovered for the first time in 2003. 
H1N2 viruses found in Denmark are reassortants of “avian-like” H1gene and a 
European  “swine-like” N2 gene (Trebbien et al., 2013). In 2009 and 2010 
there were the first reported isolations and demonstrations of natural 
reassortants of H1N2 viruses in pigs in Sweden (Bálint et al., 2009). The   14 
characterized Swedish isolates possessed avian-like SIV H1N1 HA and 
European H3N2 SIV-like NA (Metreveli et al., 2011).   
After introduction of the H1N1pdm virus into the European pig population, 
some novel H1N2 swine influenza reassortant strains have been characterized 
in Europe. In Italy, a novel H1N2 reassortant was characterized which obtained 
seven genes from the H1N1pdm and NA closely related to two “avian-like” 
H1N2 swine influenza viruses, previously isolated in Sweden and Italy 
(Moreno et al., 2011). Also in the United Kingdom, a novel H1N2 reassortant 
comprised of HA and NA genes of the “human-like” swine influenza H1N2 
and the rest six internal genes of H1N1pdm, was detected (Howard et al., 
2011). In 2012 in Germany, novel H1N2 strains have been characterized that 
have seven genes of H1N1pdm and the NA gene of the European human H3N2 
lineage (Lange et al., 2013).  
Later in autumn 2013 a reassortment between H1N1pdm and Swedish   
“avian-like” H1N2 strains was detected, resulting in a novel reassortant H1N2 
strain. The characterized novel Swedish H1N2 reassortant strain showed that 
seven genes belong to the H1N1pdm virus and the NA gene is similar  to 
A/swine/Sweden/1021/2009(H1N2) and A/swine/Sweden/9706/2010(H1N2) 
(personal communication Siamak Zohari, SVA 2013). 
 
1.1.5 Epidemiology   
Continuous circulation of influenza A viruses in pigs can result in the 
production of new reassortant viruses. In Europe, other subtypes have 
sporadically been isolated and then disappeared from pigs. For example, 
subtype H1N7 (human and equine) in 1992 from England (Brown et al., 1997) 
and H3N1 from Italy (Moreno et al., 2009) have been isolated but have not 
been established in the pig population. These novel subtypes have not been 
widespread either in Great Britain or in the Italian pig populations. This could 
be explained by the budding interplay activities of H3 and N1 and H1 and N7 
proteins are not being as well functionally balanced as are the H1 and N2 
proteins. In North America and Asia, many other subtypes have been described 
in pigs (H4N6, H3N3, H9N2, H5N1, H2N3), but no evidence has been found 
of such viruses circulating in European pigs. It is widely accepted that wild 
aquatic birds are reservoirs of all influenza A viruses for other species 
(Fouchier et al., 2005). Due to their susceptibility to both human and avian 
influenza A viruses (Ito et al., 1998; Webster et al., 1992), swine have been 
postulated to play an important role in interspecies transmission, by acting as a 
mixing vessel for reassortment between viruses specific to different host 
species (Scholtissek, 1994), which is an important mechanism in the evolution   15
of human pandemics (Webster et al., 1992). This has been verified in Europe, 
in Italian pigs, when Castrucci et al. (1993) detected reassortment of human 
and avian viruses, and it is best exemplified by the appearance of the 2009 
H1N1pdm influenza virus (Fig 1). Pigs were found to be susceptible to the 
2009 H1N1pdm, which was transmitted to this animal species in several 
countries. 
The classical swine influenza virus lineage became established in domestic 
pigs in 1918-1920, similar to the 1918 pandemic H1N1virus. In 1979 an   
“avian-like” H1N1 virus appeared in European pigs and was circulating with 
the  classical swine H1N1 viruses. In 1998, a North American triple H3N2 
reassortant virus was reported in the United States, derived from three different 
origins: an avian virus that circulated in wild birds, classical swine H1N1 
viruses, and a human H3N2 influenza virus. This triple reassortant swine origin 
influenza virus became predominant in the North American pig population. 
These are the viruses that provided genomic segments for the 2009 H1N1pdm 
virus. This 2009 H1N1pdm virus has PB2 and PA segments from North 
American avian viruses: the PB1 segment is from the human H3N2 viruses, 
(from the 1968 pandemic, whose PB1 segment is of avian origin); the HA (of 
the H1 subtype), NP and NS segments are from classical swine H1N1 viruses 
(also avian origin); and the NA (of the N1 subtype) and M segments are from 
Eurasian 1979 “avian-like” swine viruses. 
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Figure 1. Emergence of the 2009 pandemic H1N1 virus. This 2009 H1N1pdm virus has PB2 and 
PA segments from North American avian viruses; the PB1 segment is from the human H3N2 
viruses, (from the 1968 pandemic whose PB1 segment is of avian origin); the HA (of the H1 
subtype), NP and NS are segments are from classical swine H1N1 viruses (also avian origin); and 
the NA (of the N1 subtype) and M segments are from Eurasian 1979 “avian-like” swine viruses. 
 
The circulation of SIVs in Asia is more complex than it is elsewhere. Some 
SIVs of the North American and European lineages have been found and 
detected in Asia; this could be the result of importation of live pigs from these 
regions, but there are several lineages that are found only in Asia. It is not so 
surprising, therefore, that the circulation of entirely avian influenza (AI) 
viruses in pigs in nature is a relatively rare event. Still, there is circumstantial 
evidence that the genes of avian viruses may persist after reassortment with 
one or more influenza viruses endemic in pigs. As an example, H3N2 and 
H1N2 influenza viruses carrying mixtures of avian, swine and human influenza 
virus genes have become enzootic in Europe. This probably means that genetic 
reassortments or mutations are needed for successful transmission of AI 
viruses between pigs. Therefore it is of major importance to monitor the 
evolution of SI in pigs, and in particular monitor the hallmarks of species 
adaptation to humans. 
1.2  Influenza virus biology, genome structure and organization  
1.2.1 Classification   
Influenza viruses A, B and C together with Thogotovirus, Isavirus and the 
newly discovered Quaranfilvirus are genera in the family of Orthomyxoviridae 
(Perez et al., 2011). The name of the family is derived from Greek – orthos, 
which means correct or right and myxa, which means mucus. Influenza types B 
and C occur in humans, although not exclusively; influenza C virus has been 
isolated from swine (Yuanji & Desselberger, 1984) and influenza B virus from 
seals (Osterhaus et al., 2000). Influenza A viruses have been isolated from a 
large variety of animals, including humans, pigs, mink, horses, dogs, sea 
mammals and birds (Webster et al., 1992; Alexander, 1982) and can cause 
serious disease with pandemic characteristics. 
Influenza A viruses are further divided into subtypes based on the antigenic 
properties of the external glycoproteins, haemagglutinin (HA) and 
neuraminidase (NA). Sixteen antigenically different HAs (H1–H16) and nine 
different NAs (N1–N9) have been identified and their combination designates 
the subtype of the virus (Fouchier et al., 2005; Alexander, 2000). It is widely 
accepted that wild aquatic birds like ducks, gulls, and other seabirds are the   17
the subtype of the virus (Fouchier et al., 2005; Alexander, 2000). It is widely 
accepted that wild aquatic birds like ducks, gulls, and other seabirds are the 
most important reservoirs of these viruses, because influenza viruses of all 
possible subtypes have been identified in this population. It is thought that they 
are the source of viruses that infect other avian and mammalian species. 
Recently, two novel influenza A viruses were discovered in bats from 
Guatemala (HA17NA10) and Peru (HA18NA11) suggesting that these species 
may constitute another reservoir with even greater genetic diversity (Tong et 
al., 2013; Tong et al., 2012). Influenza virus strains are given names according 
to their type (A, B or C), host (from which the virus was isolated), geographic 
location, number of the isolate, the year of isolation and HA and NA subtypes. 
For example: the first isolate of an H1N2 subtype virus isolated from pig in 
Sweden in 2009 is named: A/swine/Sweden/1021/2009(H1N2). 
1.2.2 Virion  structure   
Influenza A virions are enveloped and pleomorphic. Their shape varies from 
small and spherical (cell culture isolates) with a diameter of about 100 nm, to 
long and filamentous of more than 300 nm, which has been observed especially 
in fresh clinical isolates (Chu et al., 1949). The influenza A virus genome 
consists of eight single stranded, negative-sense RNAs that encode for up to 
twelve proteins. These eight segments that comprise the influenza virus 
genome form viral RNPs, and are packaged into the virus particle (McGeoch et 
al., 1976). The influenza A virus particle has a lipid membrane, derived from 
the host cell during the viral budding process (Cheung & Poon, 2007; Lamb & 
Krug, 2001; Webster et al., 1992), and this where three viral proteins HA, NA 
and transmembrane protein M2 (Lamb & Krug, 2001) are inserted. The HA 
and NA are spike glycoproteins that are rod-shape and mushroom-shaped, 
respectively (Fig. 2). 
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Figure 2. Schematic graph of an influenza A virus particle. The genome consists of eight single-
stranded RNAs that interact with the nucleoprotein (NP) and components of the polymerase 
complex (PB2, PB1, PA). See text for details.   
The HA protein exists as a homotrimer, and it plays important roles in the 
influenza virus life cycle by mediating receptor binding and membrane fusion. 
The cleavability of the HA protein by the host cell proteases determine the 
pathogenicity of influenza viruses. The NA protein is a homotetramer, and it 
plays a role in the release of virions by destroying receptors of the host and 
viral membranes. This is necessary for progeny virions to be released from the 
cell surface. The transmembrane protein M2 functions as an ion channel 
(Holsinger et al., 1994; Wang et al., 1994), which has a role in virus entry, 
assembly and budding. Under the viral lipid envelope there is an M1 protein 
layer (Ruigrok et al., 1989). The ribonucleoprotein (RNP) complex is made up 
of the viral RNA segments, three polymerase proteins (basic polymerase 
protein 2 (PB2), basic polymerase protein 1 (PB1) and acidic polymerase 
protein (PA) and the nucleoprotein (NP) (Shaw & Palese, 2008 ). The nuclear 
export protein (NEP; also called non-structural protein 2, NS2) is also present 
inside the viral particle (Palese & Shaw, 2006) and it functions as a nuclear 
export protein for vRNA in infected cells (O'Neill et al., 1998). Inside of the 
influenza A virion, all eight genomic RNAs (vRNA) are individually bound to 
the nucleoprotein (NP) and to the influenza virus RNA polymerase to form 
RNP complexes (Lamb & Choppin, 1983). Influenza A viruses increase the 
coding capacity of their genomes by splicing and using alternative open 
reading frames. Some viral isolates can express the PB1-F2 and PB1 N40   19
proteins encoded within the PB1 gene (Wise et al., 2009; Chen et al., 2001). 
The M and NS gene mRNAs are spliced, and thus can encode the M2 and the 
NS2 proteins, respectively (Lamb & Choppin, 1981; Lamb & Choppin, 1979).  
The PB1-F2 and NS1 proteins are the only non-structural proteins. Each viral 
gene has non-translated (NTR) regions at both the 5’ and 3’ ends that contain 
replication, transcription, and packaging signals. The 13 and 12 nucleotides 
(nt) at the 5’and 3’ ends, respectively, are conserved among all segments of 
influenza A viruses (Palese & Shaw, 2006). The sizes of the viral RNA 
segments and the proteins encoded are shown in Table 1. 
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Table 1. Genome segments of influenza A virion with encoded proteins, number of nucleotides 
and amino acids and function of virus protein 
 
Genome 
Segments 
Virus 
encoded 
Nucleotides Amino 
acids 
Functions 
1  PB2  2341  759  Polymerase, host cell capped mRNA 
recognition and binding  
2 PB1, 
PB1-F2,N40 
2341        757  
      90 
Transcriptase, capped mRNA  
endonuclease activity, induction of 
apoptosis  
 
3  PA  2233  716  Required for replication, possible role in 
transcription    
 
4  HA  1778  566  Major antigenic determinant, functions  
in virus binding to cell surface receptors 
and fusion 
 
5  NP  1565  498  Associated with RNA segments to form  
ribonucleoprotein  
 
6  NA  1413  454  Functions in virus release; targets of  
neuraminidase inhibitors  
 
7 M1 
M2 
1027        252 
      97 
Major virion component; involved in  
RNP transport out of nucleus, ion 
channel activity  
 
8         NS1 
       NEP 
890        230 
      121 
Inhibits mRNA transport from nucleus;  
viral nuclear export protein 
 
 
1.3  Replication of influenza A viruses  
The replication processes of influenza A viruses can be divided into the 
following   fundamental steps (Fig. 3).   21
1.3.1  Attachment and entry  
To initiate infection and replication, the HA protein on the virus surface 
attaches to the host cell receptors, containing terminal -2,6 linked or -2,3 
linked sialic acid (-2,6-SA or -2,3-SA). Avian and equine influenza viruses 
recognize mainly -2,3-SA receptors (Gambotto et al., 2008; Horimoto & 
Kawaoka, 2005; Connor et al., 1994). Humans have both type of receptors but 
human viruses can mainly recognize -2,6-SA receptors (Horimoto & 
Kawaoka, 2006). Pigs, on their tracheal epithelial cells, have both (-2, 6-SA 
or -2, 3-SA) types of receptors, which may explain why they are susceptible 
to viruses of both human and avian origin (Webster et al., 1992).  
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Translation  lt
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Figure 3. To initiate infection and replication, the HA protein on the virus surface attaches to the 
host cell receptors. After cell attachment, the virus enters via receptor-mediated endocytosis, the 
viral RNPs (vRNP) are released into the cytoplasm and transported to the nucleus where viral 
RNA (vRNA) synthesis takes place. vRNAs are used as templates by the viral RNA polymerase, 
and synthesize two kinds of positive-strand RNAs. Complementary RNAs (cRNAs) are full-
length copies of the vRNAs, and viral mRNAs are capped and polyadenylated and are exported to 
the cytoplasm for translation. Once they are translated, into some of the viral proteins are 
imported back to the nucleus to facilitate replication and transcription. After that newly 
synthesized RNPs are exported to the cytoplasm for packaging with the help of M1 and NEP. 
Viral HA, NA and M2 are matured in the Golgi apparatus (Golgi) and collecting at the plasma 
membrane where, with help of M1, the production of viral particles begins. As a consequence, 
budding starts and progeny virus are released from the cell by the activity of NA that destroys   22 
receptors of the host and viral membranes. This is necessary for progeny virions to be released 
from the cell surface. 
1.3.2  Fusion and uncoating 
After cell attachment, the virus enters by the receptor-mediated endocytosis of 
the virus particle via clathrin-coated pits (this process is dependent on a 
cellular GTPase) (Cross et al., 2001). The endocytosis formed vesicles with the 
viral particles fuse to the endosomes in the cytoplasm (Skehel & Wiley, 2000). 
Influenza viruses need low pH to fuse with endosomal membranes. After 
binding to the host cell surface and undergoing endocytosis, the low pH of the 
endosome activates fusion of the viral membrane with that of the endosome.  
The low pH (5.0) in the endosomes results in conformational changes of the 
HA molecules that have been cleaved into HA1 and HA2 and attached by 
disulfide bonds (Skehel et al., 1982). The concerted structural change of the 
HA molecules opens up a pore, which releases the viral RNPs into the 
cytoplasm of the cell. Successful uncoating is dependent on the presence of the 
M2 protein as well, which has ion channel activity (Pinto et al., 1992).  It has 
been shown that amantadine and rimantadine can block both the M2 protein 
ion channel activity (Fig. 3) and uncoating, and they thus act as anti-influenza 
drugs (Chizhmakov et al., 1996; Wang et al., 1993; Sugrue & Hay, 1991). The 
HA-mediated fusion of the viral membrane with the endosomal membrane and 
the M2-mediated release of the RNP result in the appearance of free RNP 
complexes in the cytoplasm.  This completes the uncoating process (Martin & 
Helenius, 1991). 
1.3.3  Transcription and replication 
After the uncoating, the viral ribonucleoproteins (vRNPs) are transported into 
the nucleus (Helenius, 1992), where viral RNA synthesis takes place. Viral 
RNAs (vRNAs) are used as templates by the viral RNA polymerase, and 
produce two kinds of positive-strand RNAs (Krug et al., 1989). 
Complementary RNAs (cRNAs) are full-length copies of the vRNAs, and 
mRNAs are capped and polyadenylated (Shih & Krug, 1996; Plotch et al., 
1981). The addition of the poly (A) tail occurs at a stretch of uridine residues 
close to the 5' end of the vRNAs. The mRNAs located at the 5' end of the 
vRNAs do not have genetic information. Amplification of the vRNA is done 
via copying of the full-length cRNAs into new full-length vRNA molecules. 
1.3.4  Assembly and release 
The viral mRNAs are transported from the nucleus into the cytoplasm and it’s 
translated into proteins. The translated viral proteins that are needed in   23
replication and transcription are imported back into the nucleus again. After 
that, newly synthesized RNPs are exported to the cytoplasm for packaging, 
with help of the M1 and NEP. Viral HA, NA and M2 are matured in the Golgi 
apparatus (Golgi) and collect at the plasma membrane, where with help of M1, 
the production of viral particles begins. As a consequence, budding starts and 
the progeny virus is released from the cell by the activity of NA that is destroys 
receptors of the host and viral membranes. This is necessary for progeny 
virions to be released from the cell surface. The NA is also the main target of 
the antiviral drugs zanamivir and oseltamivir. These inhibitors interfere with 
the activity of the NA protein (Fig. 3) that is crucial for efficient release from 
the cell surface and subsequent spread to other cells.  
1.4  Antigenic variation of influenza A viruses 
1.4.1 Drift   
Using two different mechanisms influenza A viruses continuously change their 
genetic form/antigenicity. The viral RNA polymerase does not have proof 
reading activity when synthesizing the genome. This results in point mutations, 
called genetic drift (Both et al., 1983), the rate of mutations being about one 
nucleotide change for one copied genome (Drake, 1993). The highest 
evolutionary rates are observed in the HA and NA proteins. The antigenicity 
that the population develops drives the selection of the generated mutants and 
this is called antigenic drift. Antigenic drift is associated with seasonal 
epidemics, where new strains have amino acid changes in the HA and NA 
genes. These changes can overcome existing immunity in humans, leading to 
seasonal influenza epidemics. 
1.4.2 Shift   
The influenza A virus genome is segmented, and when two or more different 
virus subtypes infect a single cell new strains can unexpectedly be produced by 
reassortment, leading to antigenic shift. This is associated with the emergence 
of new pandemic influenza viruses. This process is able to introduce new 
proteins, which can drastically change the biology of the virion. For example, it 
played a huge role in the 1957 and 1968 pandemics, appearing with new PB1, 
HA and/or NA proteins to which the human population was not immune 
(Scholtissek et al., 1978). The best example of this is the 2009 H1N1pdm 
(Fig.1).   24 
1.4.3  History of the Swedish swine influenza virus isolates used in this study 
  
Influenza H1N1 infected the Swedish pig population for the first time during 
the winter of 1982-1983, causing severe clinical signs in pigs of all ages, 
(Martinsson et al., 1983). It has circulated without obvious symptoms since 
then, although very few studies have addressed this issue. In 2002, there was 
another acute outbreak of respiratory disease in pigs related to SIV A in central 
Sweden. This virus was not fully characterised, but was later shown to be SIV 
H1N1, similar to other SIV H1N1 strains circulating in Europe at that time 
(Kiss et al., 2010). This situation changed in 2009, when the 
A/swine/Sweden/1021/2009(H1N2) virus was isolated as part of the diagnostic 
investigation of a multisite pig herd (sow pool) with 4,000 sows affected with 
severe clinical signs of respiratory disease among growers during the winter of 
2008-2009. The herd was centrally located in Sweden, 400 km from the 
southern coastline and 200 km from the western coastline. This was the first 
demonstration of H1N2 in pigs in Sweden (Wallgren et al., 2009). According 
to a national serologic screening carried out in 2006, pigs in Sweden were free 
from H1N2 at that time. During early 2010 an outbreak of the H1N2 type, 
caused severe respiratory illness in fatteners in a farrow to finish herd in 
southern Sweden, whereas sows and piglets remained healthy. This virus was 
isolated and designated as A/swine/Sweden/9706/2010(H1N2). Since these are 
the first two reported isolations and demonstrations of natural reassortants of 
H1N2 viruses in pigs in Sweden, it was important to understand how these 
viruses were related to eachother.  
However, H1N1pdm was also diagnosed and isolated in Sweden in 2013. 
As anticipated (Metreveli, 2012), later in autumn 2013 a reassortment between 
H1N1pdm and Swedish  “avian-like” H1N2 strains was detected, and found to 
be a novel reassortant H1N2 strain. The characterization of the strain showed 
that PB2, PB1, PA, HA, NP, M and NS belongs to the H1N1pdm virus and the 
NA gene is similar to A/swine/Sweden/1021/2009(H1N2) and 
A/swine/Sweden/9706/2010(H1N2) (personal communication Siamak Zohari, 
SVA 2013).  
1.5 Reverse  Genetics   
Influenza A viruses are negative sense-single strand RNA viruses, and 
therefore the introduction of genomic viral RNAs into cells does not result in 
the formation of infectious viral particles. This is in contrast to positive strand 
RNA viruses, because their genomic RNA resembles mRNA and can be 
translated into protein directly upon entering the cell. Previous experiments   25
using genetic engineering of influenza viruses have involved the reconstitution 
of functional RNP complexes in vitro and transfection of functional RNPs into 
cells (Parvin et al., 1989; Honda et al., 1987). Reverse genetics (RG) for 
negative-strand RNA viruses, developed for influenza viruses (Enami et al., 
1990; Luytjes et al., 1989), has fundamentally changed our understanding of 
their replication cycles. This methodology has allowed genetic manipulation of 
viral genomes in order to generate new viruses and clarify their biological 
properties (Fodor et al., 1999). The exact role of a gene or a single amino acid 
can be investigated by introducing appropriate mutations into the viral genome 
and then analyzing the phenotype of the rescued virus. RG is currently being 
used in several research areas including: i) characterization of virus-encoded 
virulence factors, ii) identification of virus-encoded antagonists of the 
interferon system, iii) virus replication and gene expression, iv) immune 
regulation of influenza replication, and v) vaccine development. For example, a 
live attenuated H1N1pdm 2009 vaccine, made from a plasmid-generated strain 
with HA gene mutations, gave high yields without changing the antigenicity of 
the strain (Chen et al., 2010).     27
2  Aims of the study  
The main aim of this thesis was to investigate the importance of different viral 
genes in the pathogenicity of swine influenza A virus subtype H1N2 isolated in 
Sweden. 
 
The specific aims were:    
 
•  To study and characterize SIV from the outbreak in 2009 (Paper I); 
 
 
•  To compare the two consecutive SIV isolates of 2009 and 2010 
regarding their genetic and biological characteristics (Paper II); and  
 
 
•  To determine the contribution of the PB1 gene products of these two 
SIV to virus replication and pathogenicity, by using a reverse genetics 
system (Paper III).  
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3  Materials and Methods 
This section gives a brief description of the materials and methods used in the 
studies of this thesis. More detailed descriptions are provided within each 
individual paper. 
3.1 Clinical  samples   
Lung or nasal swab samples from infected pigs were received by the National 
Veterinary Institute (SVA) for diagnostic investigation (Papers I & II). The 
sow pool was centrally located in Sweden at Moholm, 400 km from the 
southern coastline and 200 km from the western coastline, and the herd was 
located in Staffanstorp in southern Sweden. 
3.2 Virus  isolation 
The virus was isolated from the clinical material by infecting primary swine 
kidney cells or Madin Darby Canine kidney (MDCK) cells, following standard 
cell culture procedures (Papers I, II). Viral growth was determined by the 
observation of cytopathic effects (cpe), after 2– 4 days of incubation. The virus 
was aliquoted and stored at -70 ºC before use. 
3.3  RNA isolation and genomic sequence analysis 
Genetic analyses were conducted on the clinical material and on the MDCK 
cell isolates. Total RNA was prepared from virus-infected MDCK cells by the 
Qiagen RNeasy Mini kit, according to the manufacturer’s instructions (Qiagen, 
Hilden Germany) and amplified by one-step RT-PCR (QIAGEN One Step RT-
PCR Kit) using primers described previously (Kiss et al., 2008). Amplified 
products were purified using the Purification kit from Promega and sequenced   30 
using the fluorescent dye terminator method with an ABI PRISM Big DyeTM 
Terminator Cycle Sequencing v3.1 Ready Reaction kit (Perkin Elmer, 
Waltham, MA, USA) on an ABI PRISM 310 genetic analyzer according to the 
manufacturer’s recommendations (Applied Biosystems). Both strands of the 
amplicons were sequenced with the same forward and reverse primers as used 
for the amplification. Multiple alignments of the DNA sequences of each gene 
were performed using CLC, Main Workbench 5.0.2 (CLC bio A/S, Aarhus, 
Denmark). The data were transformed to MEGA format, and distance-based 
phylogenetic trees were generated using the MEGA vs 4.0 software (Tamura et 
al., 2007) with 1,000 bootstrap replicates. The phylogenetic trees were 
constructed with the Neighbour-joining method using the Kimura-two-
parameter model. The results were verified by using the character based 
method maximum parsimony, which showed similar topologies. 
3.4 Virus  titration 
Viruses were analyzed by end-point titration through cpe using 96-well plates 
containing MDCK cells, in tenfold dilutions assaying eight replicates of 50 μl 
per dilution, essentially according to (Stallknecht et al., 1990). The virus titres 
after 6–8 days were calculated according to Kärber (1931) and expressed as 
log10 tissue culture infectious dose (TCID)50 ml
-1. Haemagglutination (HA) 
titrations were performed using 0.5% suspensions of chicken erythrocytes 
according to Abusugra et al (1987) (Paper II). 
3.5  Biological titration assay and virus growth curves 
The plates were incubated up to 48 h, with microscopic evaluation of onset of 
cpe every 12 h. For the growth curves, primary foetal porcine kidney (FPK) 
cells were grown to about 80% confluency in Leighton tubes, using EMEM 
supplemented with non-essential amino acids (NEA) and containing 10% FBS. 
The tubes were inoculated with 50 μl of the three viruses, calculated to contain 
10
4 TCID50. Two tubes were frozen at -70 °C at regular intervals up to 216 h, 
with start at 0 h and subsequently from 48 h where onset of cpe could be seen 
(Paper II). 
3.6  Neuraminidase activity and inhibition assay 
The NA enzyme activity and drug inhibition assays were based on Potier et al. 
(1979), with methylumbelliferone nacetylneuraminic acid (MUNANA) as the 
substrate. Avian influenza strains, that have been shown to be oseltamivir   31
resistant and oseltamivir susceptible, were used as positive controls. The NA 
activity was plotted using GraphPad Prism Version 5 software. The oseltamivir 
resistant and oseltamivir susceptible H1N1 strains were kindly provided by 
Prof. Björn Olsen at Uppsala University, Department of Medical Sciences, 
section of Infectious Diseases (Paper II). 
3.7  Cells and viruses  
293T and PK1 cells were maintained in Dulbecco’s modified Eagle’s medium 
with 10 % fetal calf serum (FCS).  MDCK cells were grown in Eagle’s 
minimal essential medium with 10 % FCS.  Viruses were grown in 10-day-old 
specific-pathogen-free chicken embryos at 37°C (Charles River Laboratories, 
SPAFAS). All animal studies were performed according to institutional 
guidelines (Paper III). 
 
3.8  Rescue of recombinant influenza A virus  
The H1N2 SIV used in these studies included reverse genetics derived 
A/swine/Sweden/1021/2009 (r1021) A/swine/Sweden/9706/2010 (r9706), 
r1021 (9706 PB1), encoding the PB1 gene segment from the r9706 virus strain, 
and r9706 (1021 PB1), encoding the PB1 gene segment from the r1021 virus 
strain. Recombinant viruses were rescued as described previously (Gao et al., 
2008). Briefly, 293T cells were transfected with eight ambisense pDZ vectors 
expressing viral genomic RNA and viral mRNAs. The transected cells were 
harvested by pipetting and 10-day-old Specific Pathogen Free (SPF) eggs were 
inoculated by injecting of cell mixture. The inoculated SPF eggs were 
incubated at 33 or 37°C for 3 days. Allantoic fluids were harvested from 
infected chicken embryonated eggs after putting eggs at 4°C overnight (O/N).  
Hemagglutination assay (HA) was performed to confirm the rescue of 
recombinant influenza viruses, and the titers of the rescued viruses were further 
determined by plaque assay in MDCK cells. The nucleotide sequence of the 
swapped PB1 segments was sequence confirmed. 
3.9  Growth curves of recombinant and chimeric viruses  
To analyze the recombinant viruses, PK1 cells were seeded at 10
6 per well in 6 
well plates (duplicates for each virus) and were inoculated at a multiplicity of 
infection (MOI) of 0.01 PFU/cell, and incubated for 1 h at 37 °C (plates were   32 
rocked every 10 min). At the indicated time points, 0.2 ml of supernatant was 
collected for virus titration by plaque assay using MDCK cells.   
 
3.10 Infection of mice 
Six to eight week-old female C57BL/6 mice (Jackson Laboratory, Bar Harbor, 
ME) were anesthetized with an intraperitoneal (i.p.) injection of a mixture of 
ketamine and xylazine. 50hl of infectious virus diluted in phosphate-buffered 
saline (PBS) and was inoculated intranasally (i.n). To determine virus 
pathogenicity, five animals per group were infected i.n. with different doses 
(1X10
4, 1X10
5, 1X10
6 PFU) and were monitored daily for weight loss for up to 
14 days post infection (p.i). Mice showing more than 25% of body weight loss 
were considered to have reached predefined humane endpoints and were 
euthanized according to the institutional guidelines. To determine viral 
pulmonary replication kinetics, and to examine pulmonary pathology by 
histology, groups of 12 mice were inoculated with the indicated virus (1×10
5 
PFU per mouse).  Mice inoculated with PBS served as controls.  At days 2 and 
day 4 p.i., three mice per experimental group per day were euthanized.  For 
determination of virus titers, lungs were homogenized in 1 ml of PBS and viral 
titers were determined by plaque assays on MDCK cells. On days 2 and 4 p.i. 
(D2, D4), three mice per group were sacrificed for the histologic examination. 
3.11 Histopathological examination  
For the histopathological examination, the lungs from the sacrificed mice were 
removed and were infused with 10% neutral buffered formalin for >48 hours 
fixation, and then paraffin-embedded for sectioning. Lung sections were 
examined using light microscopy and images were obtained using an Olympus 
DP21 digital camera system. 
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4  Results and discussion 
4.1  Papers I & II 
In this thesis the whole genome sequences from two SIV isolates collected 
from Sweden in 2009 and 2010 were determined (Metreveli et al., 2011; Bálint 
et al., 2009). The sequence comparison revealed significant differences 
between the two consecutive H1N2 isolates. The most remarkable of these was 
a truncated coding region for PB1-F2 in the earlier isolate and a full-length 
coding region in the more recent isolate. The majority of avian influenza 
viruses, and many SIVs, harbour a 90 amino acid (aa) (full length) protein, 
while human viruses collected since 1950 have a 57 aa truncated PB1-F2 
protein. A minority of the European SIVs have stop codons after 11, 25 and 43 
amino acids (Zell et al., 2007). The 2009 Swedish H1N2 virus coded for a 57 
aa truncated version of this protein, while the 2010 isolate coded for the 90 aa 
full length protein. Another protein that has implications for the host range of 
influenza viruses, due to its role in host immune evasion, is the non-structural 
protein (NS1). The NS1 sequence of sw-H1N2-2009 and 2010 has an unusual 
PDZ binding domain (RPKV) at the C-terminal of the protein. It has recently 
been shown that the C-terminal four residues of the NS1 protein is a PDZ 
ligand domain of the X-S/T X-V type and may represent a virulence 
determinant (Ghedin et al., 2005). This particular PDZ domain has been 
reported in only three cases, all in human isolates, but never in swine isolates. 
To our knowledge, this is the first reported isolation of this unusual PDZ 
binding domain in a pig population. More studies are needed to determine the 
exact function of the PDZ motif, and may help to determine and understand the 
function of the PDZ binding domain. 
One recent study (Moreno et al., 2012) has shown that novel H1N2 swine 
influenza reassortants have derived from the 2009 H1N1pdm, with 7 genes 
well adapted to humans, and the NA gene closely related to the Swedish 2009-  34 
2010 H1N2 SIVs (Moreno et al., 2012). This new Italian H1N2 reassortant 
virus confirms the function of swine as mixing vessels for animal and human 
influenza, resulting in reassortment and host adaptation. This shows that the 
introduction of the 2009 H1N1pdm in the swine population has provided 
opportunities for reassortment, facilitating the alteration of transmissibility and 
increased virulence in the 2009 H1N1pdm virus. Genetic reassortment 
involving a virus having genes specific for replication in a new host, e.g. 
humans, can result in interspecies transmission. If the 2009 H1N1pdm is 
established in the swine population, reassortment could occur between 
influenza viruses both of mammal and avian origin, resulting in new variants 
with key molecular determinants of pathogenicity that are of concern for public 
health (Neumann et al., 2009). All of these facts could have a great impact in 
southern Sweden where most of swine and poultry are raised, and where we 
have diagnosed for the first time these uncommon avian-like reassortant H1N2 
SIV variants. Clearly, it is very important to analyze the whole genome of an 
IV isolate, and to identify amino acid changes, and possibly their effect on the 
virus’s life cycle. To allow better spread among infected cells IV HA has to 
have a matching NA (Baigent & McCauley, 2001). The role of host cellular 
factors in IV replication is at least as important as all of the other components 
of the virus (Karlas et al., 2010; Konig et al., 2010).  
In summary, the avian-like reassortant H1N2 SIV variant appears to be 
gaining a stronger foothold among Swedish pig populations, and producing 
more clinical disease. The molecular genomic differences found here indicate 
that the virus population is steadily evolving. 
 
4.2 Paper III  
 
Previous pandemic viruses have been postulated to evolve in swine from a mix 
of viral genes derived from viruses in birds, humans and swine. Studies by 
Khiabanian et al. (2009) have shown that, together with the glycoprotein 
coding segments HA and NA, the PB1 segment appears frequently in 
reassortment events among swine influenza viruses. Notably, the PB1 segment 
seems to be consistently involved in the reassortment events, particularly with 
1957 (from avian species) and 1968 (from another avian virus) pandemic 
viruses as well as into swine viruses circulating since 1998 (Richt et al., 2003; 
Zhou et al., 1999; Kawaoka et al., 1989). However, a clear mechanism of the 
preferential reassortment of this is still not fully understood.  
The possible role in viral replication and virulence of the PB1 gene 
segments present in two swine H1N2 influenza A viruses was investigated 
here. In order to determine the contribution to virus replication and   35
pathogenicity of the PB1 gene products of these two SIVs four recombinant 
swine H1N2 influenza viruses were rescued by reverse genetics. These 
recombinant viruses included the parental sw1021 and sw9706 strains, and the 
chimeric viruses r1021 (9706 PB1), encoding the PB1 gene segment from the 
sw 9706 virus strain, and r9706 (1021 PB1), encoding the PB1 gene segment 
from the sw 1021 virus strain (Fig 4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Schematics of the generated recombinant viruses r1021 and r9706 viruses and exchange 
of PB1 segment between the recombinants r1021 (9706 PB1) and r9706 (1021 PB1) 
 
The replication kinetics of the recombinant viruses (r1021 and r9706) were 
compared to the replication of the PB1 exchanged recombinants r1021(9706 
PB1) and r9706 (1021 PB1) in immortalized swine kidney cells (PK1 cells).  
Wild type sw 1021 and sw 9706 viruses were used as controls. PK1 cells were 
infected at an MOI of 0.01.  Although there were slight differences in viral 
titers between 24 and 36 hours p.i. of PK1 cells, all virus titers became equal 
by 48 hours p.i. Plaque assays conducted in MDCK cells revealed no 
differences in plaque morphology, suggesting that there were no differences in 
replication phenotypes among the different viruses. 
To determine whether the parental viruses differ in pathogenesis, and 
whether the PB1 segment could contribute to any observed differences, the 
C57 Bl/6 mouse model of influenza virus pathogenesis was utilized.  Mice 
were infected with increasing doses (1X10
4, 1X10
5, 1X10
6 PFU) of the 
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indicated viruses, and were monitored daily for weight loss for up to 14 days 
p.i. At the highest inoculum tested, r1021 was more virulent than the r9706 
virus, as evidenced by significant weight loss resulting in mice achieving the 
predefined endpoint, consistent with the differences seen for the wild type 
viruses. In the case of the chimeric viruses r1021(9706 PB1) and r9706(1021 
PB1), mice infected with 1X10
6 PFU of r9706(1021 PB1) showed a strong 
reduction in mouse weight loss (weight loss  21%). In contrast, only a mild 
reduction in weight loss (weight loss  10%) was observed for the mouse 
group inoculated with r1021 (9706 PB1) virus. The switch in virulence 
following the PB1 segment exchange showed that the PB1 gene of the r1021 
virus increased the pathogenicity in the backbone of r9706 virus (Fig 5).  
 
 
 
 
 
 
 
 
 
 
Figure 5. Pathogenesis of the chimeric r9706 (1021 PB1) virus in mice.  Six to eight week-old 
female C57BL/6 were infected with increasing doses (1X104, 1X105, 1X106 PFU) of the 
chimeric r1021 (9706 PB1) and r9706 (1021 PB1) viruses and were monitored daily for weight 
loss for up to 14 days p.i. The chimeric virus r9706 (1021PB1), carrying PB1 gene from the 
r1021, induced significantly higher weight loss than the chimeric virus r1021 (9706 PB1). 
In order to understand the differences in the virulence caused by infection of 
these recombinant and chimeric viruses, the virus replication were determined 
in the lungs of mice. Mice were infected i.n. with 1X10
5 PFU of theses viruses. 
On days 2, and 4 p.i, three mice per group were sacrificed in order to determine 
viral titers in lung homogenates. The r1021 virus replicates with higher titer in 
mice lungs compared to r9706 at both days 2 and 4. However, after the PB1 
-'
.'
/'
0'
(''
(('
()'
( ) * + , - . / 0('((()(*(+
#
3
$







 








 

(')(#0.'-($('-
0.'-#(')(($('-

-'
.'
/'
0'
(''
(('
()'
( ) * + , - . / 0('((()(*(+
#
3
$






 









 

(')(#0.'-($(',
0.'-#(')(($(',

-'
.'
/'
0'
(''
(('
()'
( ) * + , - . / 0 ('((()(*(+
#
3
$







 








 

(')(#0.'-($('+
0.'-#(')(($('+
  37
segment was swapped, the virus lung titers were also changed accordingly, 
with the titer of r9706 (1021 PB1) higher than the r1021 (9706 PB1) (Fig 6). 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Mouse lung virus titers. Six mice per virus group for r1021, r9706, r1021 (9706 PB1) 
and r9706 (1021 PB1) were infected with 1X 10
5 PFU of each virus. Three mice from each group 
were sacrificed on days 2 and 4. Lung virus titers were evaluated by infection of MDCK cells. 
These results in mice suggested that the PB1 segment might contribute to the 
virus virulence in Swedish H1N2 swine isolates. Macroscopically it was 
observed that mice inoculated i.n. with the r1021 virus showed gross pathology 
in lung appearance, with prominent edema, on both day 2 and day 4. The 
chimeric virus r9706 (1021 PB1) also showed lesions in the lung of one 
infected mouse. But by day 4 this was seen in all infected mice lungs. In 
histological examination, particular changes were seen in the lungs infected 
with the r1021 and r9706 (1021 PB1) viruses, with various degrees of 
leucocytes infiltrates and focal or diffuse alveolar damage with edema on both 
day 2 and day 4 p.i. 
The PB1 subunit is a main component of the viral RNA polymerase 
complex and has multiple active sites critical for the elongation of RNA chains 
and also for association with subunits PA and PB2 to form a heterotrimer 
(Perez & Donis, 2001; Biswas & Nayak, 1996). The PB1 gene segment is 
important in reassortment events, particularly noted in the 1957 and 1968 
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pandemic viruses as well as in swine viruses circulating since 1998 (Kawaoka 
et al., 1989; Richt et al., 2003; Zhou et al., 1999). From our previous genetic 
analysis (Metreveli et al., 2011) we saw that the PB1 genes differ at four amino 
acid positions (75, 566, 587, 618), and the 2009 isolate has a truncated coding 
region of the PB1-F2 protein where 2010 has a full length version, which 
together or individually could cause the observed  phenotypic difference 
between the viruses. Whether the truncated form in the 2009 isolate can be 
expressed as protein is not known. Regarding replication kinetics in cell 
culture, we did not find big differences between any of the viruses tested, in 
similarity with our previous results for the wild type viruses(Paper II). 
However, the aa differences could alter the structure of the PB1 protein in such 
a way that it contributes to viral fitness of the polymerase complex. If this 
could explain the difference in viral titers of mouse lung, and the pathological 
differences, remains to be seen. Further studies will be needed to identify the 
amino acid changes responsible within the PB1-segment as well as for the 
truncated PB1-F2 and full-length PB1-F2 for these phenotypes.  
Overall, the findings showed that the PB1 gene segment of SIV H1N2 virus 
is an important determinant of virulence and replication in mice. The selection 
of “virulent” highly replicative PB1s may be important when influenza viruses 
cross species barriers, or when new viral strains are generated by reassortment.  
The success of influenza virus interspecies transmission depends on the viral 
gene constellation. Successful transmission between species can follow genetic 
reassortment with a progeny virus that contains a specific gene combination 
with the ability to replicate more efficiently in the new host.  
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5  Implications for future research, 
concluding remarks 
Based on the work presented in this thesis, we aim to implement the 
aforementioned reverse genetics systems in Sweden and investigate further the 
findings from our research by studying functional differences among several 
SIV isolates. These unique reassortant variants of swine influenza virus have 
the potential to be a factor in the development of new pandemics; therefore, it 
is important to further investigate these viruses, including their replication 
characteristics, pathogenicity, virulence factors and immune modulation 
capacity in both swine and human cells. The association of truncated and full 
length forms of PB1-F2 with their biological implications for viral 
pathogenicity should be investigated by using the present RG system in a 
mouse model/swine. 
A program where swine influenza viruses are systematically monitored 
should be established because of the potential, in swine hosts, of reassortment 
of gene segments of porcine, avian and human origin. It is important to monitor 
both swine populations and humans in their vicinity. The improved knowledge 
on the biology of these H1N2 reassortant SIV types will lead to a better 
diagnostic capacity, since upon the evaluation of their antigenic potential, 
recommendations will be made on their usage as antigens in routine diagnostic 
settings. This work would increase our knowledge of the genetic structure of 
SIV, provide better understanding of the molecular details of influenza virus 
replication processes from virus entry to exit, and help to examine the role of 
viral genes as markers for pathogenicity. Continuous and further detailed 
genetic and phenotypic analyses can help to identify novel viral variants with 
greater potential to cross species barriers and those that pose health risks to not 
just swine but even to humans and other host species. 
Ultimately, this new data, when added to IV databases, will contribute to 
the general understanding of SIV biology, and potentially aid in the   40 
preparedness against influenza outbreaks. The outcome of this project directly 
contributed to the improved detection and identification of novel variants of 
influenza viruses. In turn this contributes to the prevention of new pandemics 
caused by influenza viruses of swine origin and to the development of more 
powerful and specific control measures in the event of influenza outbreaks. 
The knowledge on all of these aspects of SIVs will strongly benefit 
agribusiness and science and be of great importance for public health as well. 
In conclusion, the presented findings support the observations concerning 
the continuous reassortment process of SIVs, resulting in repeated and 
independent emergence of certain HA/NA combinations in pigs. Continuous 
and efficient surveillance and further detailed genetic and phenotypic analysis 
can help to identify novel viruses with more potential to cross species and pose 
health risks to humans. Furthermore, it is of major importance to study SIV in 
relation to its potential to evolve into severely pathogenic viruses in pigs. 
Respiratory disease of pigs is a major concern to pig health, and SIV is one 
important factor in this disease complex.  
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6 Populärvetenskaplig  sammanfattning   
Influensa A virus av subtyperna H1N1, H1N2 och H3N2 finns i svin 
populationer över hela världen, och kan där orsaka allvarlig respiratorisk 
sjukdom. Dessutom anses svin vara viktig när nya humana influensapandemier 
uppstår, och alla tidigare pandemier har sannolikt uppkommit i svin från en 
blandning av virusgener från fåglar, människor och svin. Därför är det mycket 
värdefullt att systematiskt följa utvecklingen av influensa hos svin, med fokus 
på kännetecken för dessa virus anpassning till människor. Dessa kännetecken 
är inte helt klarlagda, men innefattar förmågan att replikera snabbt och 
effektivt i humana celler, undgå medfödd immunitet och eventuellt andra ännu 
okända markörer. Av speciellt intresse är att europeiska svininfluensavirus 
(SIV) H1N2 av så kallad “aviär typ” tycks vara en av föregångarna till den 
pandemiska H1N1 influensan (H1N1pdm). Om H1N1pdm anpassar sig till 
svin kan det innebära problem för svinindustrin, eftersom majoriteten av 
svenska grisar är känsliga för viruset. Evolutionen av dessa H1N2-varianter är 
därför viktig att studera eftersom liknande SIV-typer också har beskrivits i 
Italien och Danmark, och risken för införande av stammar som nu associeras 
till de västra delarna av Europa inte bör underskattas.  
Syftet med denna studie var att klarlägga svininfluensavirusets genetik, 
samt att undersöka betydelsen av olika virala gener som markörer för 
patogenicitet, hos två SIV H1N2-stammar med olika sjukdomsalstrande 
förmåga hos grisar. De är båda av en ovanlig SIV-variant som  nyligen verkar 
att ha fått starkare fotfäste hos svenska svinbesättningar och dessutom ge 
allvarligare symptom. Virus isolerades på cellkultur från kliniskt material 
under sjukdomsutbrott 2009 och 2010, och hela virusgenomen 
sekvensbestämdes. Resultaten visade, för första gången i svenska 
svinbesättningar, naturlig reassortment av SIV-H1N2 virus, med aviär-liknande 
SIV H1N1 HA, och europeisk H3N2 SIV-liknande NA. Vid jämförelse av 
sekvenserna sågs stora skillnader mellan de två genomen, exempelvis i PB1-   42 
gensegmentet, som ofta har visat sig bytas ut vid reassortment. Aviära PB1-
gensegment har introducerats vid influensapandemierna 1957 och 1968, samt i 
SIV som cirkulerar sedan 1998. Mekanismen bakom denna preferens är inte 
helt klarlagd. Så kallad omvänd genetik, eller ”Reverse genetics” användes för 
att vidare studera genetiken bakom de båda virusens? olika patogenicitet, med 
fokus på PB1-gensegmentet.  För detta ändamål utvecklades fyra rekombinanta 
virus, de båda ursprungsvirusen sw1021 och sw9706, samt de chimära virusen 
r1021(9706 PB1) och r9706(1021PB1) där PB1 gensegmentet var utbytt mot 
det andra virusets variant. Ökad virulens och replikation kunde härröras till 
PB1-segmentet från r1021 i infektionsförsök på mus. Sammanfattningsvis 
visade resultaten att PB1-gensegmentet hos SIV H1N2-viruset är en viktig 
faktor för virulens och replikation i möss. Våra iakttagelser stödjer tidigare 
observationer av SIVs benägenhet till reassortment hos grisar, vilket resulterar 
i en upprepad och oberoende uppkomst av vissa HA / NA kombinationer, 
liksom av övriga gensegment. Detta kan leda till nya och mer 
sjukdomsframkallande varianter av influensavirus hos gris. En kontinuerlig och 
effektiv övervakning samt en mer detaljerad genetisk och fenotypisk analys 
kan bidra till att identifiera sådana nya virala varianter, som kan ha större 
potential att korsa artbarriärer och medföra hälsorisker för människor såväl 
som andra värddjur. 
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